192 related articles for article (PubMed ID: 24525699)
21. Long-term efficacy of imatinib for treatment of metastatic GIST.
Patel S
Cancer Chemother Pharmacol; 2013 Aug; 72(2):277-86. PubMed ID: 23503753
[TBL] [Abstract][Full Text] [Related]
22. Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.
Benjamin RS; Blanke CD; Blay JY; Bonvalot S; Eisenberg B
Oncologist; 2006 Jan; 11(1):9-20. PubMed ID: 16401709
[TBL] [Abstract][Full Text] [Related]
23. [Long-term survival in a case of recurrent gastrointestinal stromal tumor treated with intermittent or low-dose imatinib].
Kurata Y; Takaishi S; Sakuma Y; Iwasaki K; Nimura Y; Tohma T; Kagaya A; Yamamoto Y; Matsubara H
Gan To Kagaku Ryoho; 2014 Mar; 41(3):379-82. PubMed ID: 24743288
[TBL] [Abstract][Full Text] [Related]
24. [A case of a giant rectal gastrointestinal stromal tumor radically resectable after treatment with neoadjuvant imatinib mesylate].
Sassa M; Kobayashi Y; Sugeno H; Iwadate M; Suzuki S; Endo Y; Nakamura I; Ohki S; Takenoshita S
Gan To Kagaku Ryoho; 2013 Jul; 40(7):937-41. PubMed ID: 23863741
[TBL] [Abstract][Full Text] [Related]
25. Recurrent GI bleeding and surgery following the initial response to imatinib therapy in GIST of the stomach.
El Hajj II; Chehal A; El Saghir NS
Dig Dis Sci; 2005 Jan; 50(1):65-9. PubMed ID: 15712639
[No Abstract] [Full Text] [Related]
26. Updates on the management of gastrointestinal stromal tumors.
Bamboat ZM; Dematteo RP
Surg Oncol Clin N Am; 2012 Apr; 21(2):301-16. PubMed ID: 22365521
[TBL] [Abstract][Full Text] [Related]
27. [Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors].
Zheng S; Jia J; Pan YL; Tao DY; Lu HS
Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):42-3. PubMed ID: 23611272
[No Abstract] [Full Text] [Related]
28. Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy.
Shankar S; Dundamadappa SK; Karam AR; Stay RM; van Sonnenberg E
Acta Radiol; 2009 Oct; 50(8):837-44. PubMed ID: 19735005
[TBL] [Abstract][Full Text] [Related]
29. Reintroduction of imatinib in GIST.
Reid T
J Gastrointest Cancer; 2013 Dec; 44(4):385-92. PubMed ID: 23921604
[TBL] [Abstract][Full Text] [Related]
30. [New surgical approaches to localized and advanced gastrointestinal stromal tumors (GIST)].
Bonvalot S; Honoré C
Bull Acad Natl Med; 2012; 196(4-5):855-60; discussion 860. PubMed ID: 23550448
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant imatinib for GIST: the pie is shrinking.
Balachandran VP; DeMatteo RP
Ann Surg Oncol; 2014 Oct; 21(11):3365-6. PubMed ID: 25120253
[No Abstract] [Full Text] [Related]
32. Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib.
Bauer S; Hartmann JT; de Wit M; Lang H; Grabellus F; Antoch G; Niebel W; Erhard J; Ebeling P; Zeth M; Taeger G; Seeber S; Flasshove M; Schütte J
Int J Cancer; 2005 Nov; 117(2):316-25. PubMed ID: 15900603
[TBL] [Abstract][Full Text] [Related]
33. Multimodal functional imaging for early response assessment in GIST patients treated with imatinib.
Revheim ME; Hole KH; Bruland OS; Reitan E; Bjerkehagen B; Julsrud L; Seierstad T
Acta Oncol; 2014 Jan; 53(1):143-8. PubMed ID: 23710697
[No Abstract] [Full Text] [Related]
34. Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapy.
Lartigue L; Neuville A; Lagarde P; Brulard C; Rutkowski P; Dei Tos P; Wardelmann E; Debiec-Rychter M; Italiano A; Coindre JM; Chibon F
Eur J Cancer; 2015 Jan; 51(1):75-83. PubMed ID: 25466504
[TBL] [Abstract][Full Text] [Related]
35. [A case of rectal GIST treated by perineal partial rectal resection using laparoscopic surgery].
Babaya A; Nakata K; Fukunaga M; Hoshino H; Kawabata R; Yamamoto T; Kawase T; Kimura Y; Ohzato H
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1846-8. PubMed ID: 25731350
[TBL] [Abstract][Full Text] [Related]
36. Hepatic metastasis with heterologous rhabdomyoblastic differentiation in a patient with gastrointestinal stromal tumor treated with imatinib.
Vij M; Patra S; Rela M
Indian J Pathol Microbiol; 2013; 56(3):291-3. PubMed ID: 24152514
[TBL] [Abstract][Full Text] [Related]
37. New fronts in the adjuvant treatment of GIST.
Reichardt P; Joensuu H; Blay JY
Cancer Chemother Pharmacol; 2013 Oct; 72(4):715-23. PubMed ID: 23934322
[TBL] [Abstract][Full Text] [Related]
38. [New prospective on adjuvant treatment for gastrointestinal stromal tumors].
Pan ZZ; Wu XJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):212-5. PubMed ID: 23536337
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy observation on imatinib adjuvant therapy with longer duration in patients with gastrointestinal stromal at intermediate or high risk of recurrence].
Li J; Dang YZ; Gao J; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):216-20. PubMed ID: 23536338
[TBL] [Abstract][Full Text] [Related]
40. Resection of focally progressive gastrointestinal stromal tumours resistant to imatinib therapy.
Tse GH; Wong EH; O'Dwyer PJ
Surgeon; 2012 Dec; 10(6):309-13. PubMed ID: 22123434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
